Litigation

HB Ad Slot
HB Mobile Ad Slot

The National Law Review is a no-log-in resource of legal articles addressing litigation, trial practice, appellate practice, and alternative dispute resolution. We provide legal news on the most recent litigated business and commercial cases including antitrust, banking and financial institutions, construction, complex disputes/class actions involving multi-parties and multi-jurisdictions, communications, employment law, environmental actions, government enforcement defense, insurance, intellectual property, mergers and business combinations, products liability, professional liability, real estate and development, environmental, securities enforcement, white-collar criminal actions, and trust and estate litigation. Details of actions by federal and state and local regulatory agencies as well as private actions from across the U.S. are added daily.

The legal experts who write for the National Law Review cover the federal circuit courts as well as the Supreme Court, analyzing the decisions and opinions from the justices at these levels and parsing the meaning and greater context of these decisions.  For coverage of the circuit courts and the decisions at the Supreme Court, the National Law Review has breaking news coverage of these issues. Additionally, coverage of litigation as a process, including rules of evidence, jury selection, and information on expert witnesses is available on the site.

Along with traditional litigation, the National Law Review also covers alternate dispute resolution (ADR), as well as the viability of Arbitration Agreements in a variety of contexts. The benefits of mediation as opposed to litigation, and the benefits of arbitration.  Compulsory arbitration clauses in agreements relating to major corporations, shareholder agreements, or multinational agreements, are covered on the National Law Review.

Additionally, the National Law Review covers trends in -e-discovery and regulations in document analysis and trial preparation. 

We also serve as a resource for the latest developments in civil proceduree-discovery, trial practice, appellate practice, and alternative dispute resolution, including mediation and arbitration involving both binding adversarial proceedings and non-binding voluntary procedures before neutral third parties.

National Law Review Litigation & Class Action Law TwitterFor hourly updates on the latest news about Litigation, Class Action Law Suits, Appellate Rulings, TCPA, and more, be sure to follow our Litigation Law X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Litigation, Trial, ADR, E-Discovery & Court News

Title
Custom text Organization Sort descending
Sep
10
2015
S.D.N.Y. Dismisses Plaintiffs’ “Shadow Insurance” Class Action Claims Foley & Lardner LLP
Nov
1
2017
Seventh Circuit To Welcome First New Judge Since 2009 Foley & Lardner LLP
Jul
3
2023
Supreme Court Redefines “Undue Hardship” when Addressing Religious Accommodation Requests under Title VII Foley & Lardner LLP
Jan
15
2019
Orange Book Listing Creates Injury To Support Standing To Appeal IPR Decision Foley & Lardner LLP
Oct
6
2016
Bankruptcy Homeowners Cannot Surrender Residence in Bankruptcy and Later Fight Lender’s Foreclosure Foley & Lardner LLP
Mar
26
2020
Seventh Circuit Addresses Waiver of Right to Arbitrate Foley & Lardner LLP
Apr
1
2020
Internal Investigations and Privileges: Two More Courts Rule Foley & Lardner LLP
Feb
5
2019
Federal Circuit Affirms PTAB Lead Compound Analysis Upholding Vimpat Lacosamide Patent Foley & Lardner LLP
Jan
9
2018
Prosecution History Informs Claim Meaning Even Without Unmistakable Disclaimer Foley & Lardner LLP
Feb
27
2019
Don’t Delay Rule 23(f) Appeal Foley & Lardner LLP
Apr
28
2020
Federal Circuit Finds Medical Device Claims Eligible For Patenting At Alice Step One Foley & Lardner LLP
Dec
3
2015
Federal Circuit Confirms Constitutionality of IPR Proceedings in MCM Portfolio v. Hewlett-Packard Foley & Lardner LLP
Apr
15
2019
A Review of Recent Whistleblower Developments: April 15th Foley & Lardner LLP
Dec
8
2015
Proposed Rule Changes For IPR Appeals Foley & Lardner LLP
Jun
21
2022
340B Hospitals Win in Medicare OPPS Supreme Court Decision Foley & Lardner LLP
Aug
23
2023
Nothing for Free: Federal Circuit Clarifies Commercial Success is All About Sales Foley & Lardner LLP
Jan
16
2017
Supreme Court Will Judge Biosimilar Patent Dance Foley & Lardner LLP
Jan
10
2016
Federal Circuit Orders IPR Remand On Board's Treatment Of Evidence Foley & Lardner LLP
Apr
4
2018
Second Circuit Suggests that the Value of an Accused Secondary Use Dictates What Constitutes Fair Use Foley & Lardner LLP
Apr
24
2018
Is the International Trade Commission the Most Patent-Friendly Venue with a Complainant Success Rate Near 90%? Foley & Lardner LLP
Apr
25
2018
Supreme Court Holds That the PTO Cannot Institute Review on Only Some of the Challenged Claims Foley & Lardner LLP
Jun
28
2019
Recent Decision from District of Oregon Denying Enhanced Damages Underscores Vast Liability Exposure Under the TCPA Foley & Lardner LLP
May
2
2018
Heightened Ascertainability Remains a Formidable Requirement to Achieving Class Certification in the Third Circuit: Administrative Feasibility Following City Select v. BMW Bank of North America Foley & Lardner LLP
Mar
14
2017
Biosimilar Remedies Not Limited Without Full Patent Dance Foley & Lardner LLP
Feb
16
2016
Athletic Shoe Lawsuits are Off and Running Foley & Lardner LLP
May
28
2018
Medical Treatment Patent Claims Held Patentable Subject Matter Under the Alice/Mayo Section 101 Test Foley & Lardner LLP
Jun
12
2018
China Agritech: The Supreme Court Ends Class Action “Stacking” Foley & Lardner LLP
Apr
9
2015
Apotex Has Standing Despite Benicar Patent Disclaimer Foley & Lardner LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins